Home Cart 0 Sign in  

[ CAS No. 57602-02-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 57602-02-5
Chemical Structure| 57602-02-5
Structure of 57602-02-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 57602-02-5 ]

Related Doc. of [ 57602-02-5 ]

Alternatived Products of [ 57602-02-5 ]

Product Details of [ 57602-02-5 ]

CAS No. :57602-02-5 MDL No. :MFCD07369317
Formula : C10H20Br2O4 Boiling Point : -
Linear Structure Formula :- InChI Key :VYNNYZUBABMNTB-UHFFFAOYSA-N
M.W : 364.07 Pubchem ID :11089808
Synonyms :
Chemical Name :1,14-Dibromo-3,6,9,12-tetraoxatetradecane

Calculated chemistry of [ 57602-02-5 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 13
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 70.26
TPSA : 36.92 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.7 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.96
Log Po/w (XLOGP3) : 1.16
Log Po/w (WLOGP) : 1.84
Log Po/w (MLOGP) : 1.03
Log Po/w (SILICOS-IT) : 3.23
Consensus Log Po/w : 2.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.97
Solubility : 3.9 mg/ml ; 0.0107 mol/l
Class : Very soluble
Log S (Ali) : -1.53
Solubility : 10.7 mg/ml ; 0.0295 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -4.54
Solubility : 0.0104 mg/ml ; 0.0000285 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.22

Safety of [ 57602-02-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 57602-02-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 57602-02-5 ]
  • Downstream synthetic route of [ 57602-02-5 ]

[ 57602-02-5 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 4792-15-8 ]
  • [ 57602-02-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 6, p. 1279 - 1290
[2] Journal of Heterocyclic Chemistry, 1990, vol. 27, # 4, p. 347 - 349
[3] Journal of Organic Chemistry, 1988, vol. 53, # 10, p. 2268 - 2274
[4] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1995, # 4, p. 697 - 706
[5] Patent: US2882321, 1954, ,
[6] Chemical Communications, 1998, # 13, p. 1371 - 1372
[7] Journal of Organometallic Chemistry, 1999, vol. 572, # 1, p. 93 - 104
[8] Journal of Organic Chemistry, 2000, vol. 65, # 11, p. 3292 - 3298
[9] Steroids, 2006, vol. 71, # 10, p. 911 - 921
[10] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 3, p. 557 - 560
[11] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 2, p. 636 - 643
[12] Patent: US2016/82117, 2016, A1,
[13] Supramolecular Chemistry, 2018, vol. 30, # 3, p. 184 - 195
  • 2
  • [ 109789-39-1 ]
  • [ 57602-02-5 ]
YieldReaction ConditionsOperation in experiment
2.73 g With tetrabutylammomium bromide In acetonitrile for 16 h; Inert atmosphere Example 2
Pentaethyleneglycol disulfonate (3.94 g, 10 mmol) and 13.3 g tetrabutyl ammonium bromide are dissolved in acetonitrile 50 mL, and stirred and react 16 hours under nitrogen gas protection. Solvent is evaporated out, acetic ether and water are added for extraction, extract is dried by using anhydrous sodium sulfate, concentrates and goes through column separation to obtain 2.73 g product, with a yield rate 75percent. 1H-NMR (CDCl3): 3.49 (t, 4H), 3.69 (s, 12H), 3.84 (t, 4H).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 3, p. 557 - 560
[2] Steroids, 2006, vol. 71, # 10, p. 911 - 921
[3] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 2, p. 636 - 643
[4] Patent: US2016/82117, 2016, A1, . Location in patent: Paragraph 0046
  • 3
  • [ 55400-73-2 ]
  • [ 57602-02-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 2, p. 636 - 643
  • 4
  • [ 5197-65-9 ]
  • [ 57602-02-5 ]
Reference: [1] Canadian Journal of Chemistry, 1988, vol. 66, p. 1097 - 1108
  • 5
  • [ 112-60-7 ]
  • [ 57602-02-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 2, p. 636 - 643
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 57602-02-5 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 5414-19-7

[ 5414-19-7 ]

1-Bromo-2-(2-bromoethoxy)ethane

Similarity: 0.93

Chemical Structure| 6482-24-2

[ 6482-24-2 ]

1-Bromo-2-methoxyethane

Similarity: 0.86

Chemical Structure| 54149-16-5

[ 54149-16-5 ]

2-(2-Bromoethoxy)propane

Similarity: 0.76

Chemical Structure| 111-77-3

[ 111-77-3 ]

2-(2-Methoxyethoxy)ethanol

Similarity: 0.64

Chemical Structure| 143-24-8

[ 143-24-8 ]

2,5,8,11,14-Pentaoxapentadecane

Similarity: 0.64

Bromides

Chemical Structure| 5414-19-7

[ 5414-19-7 ]

1-Bromo-2-(2-bromoethoxy)ethane

Similarity: 0.93

Chemical Structure| 6482-24-2

[ 6482-24-2 ]

1-Bromo-2-methoxyethane

Similarity: 0.86

Chemical Structure| 54149-16-5

[ 54149-16-5 ]

2-(2-Bromoethoxy)propane

Similarity: 0.76

Chemical Structure| 39267-79-3

[ 39267-79-3 ]

3-Bromooxetane

Similarity: 0.67

Chemical Structure| 4360-63-8

[ 4360-63-8 ]

2-Bromomethyl-1,3-dioxolane

Similarity: 0.64

Ethers

Chemical Structure| 5414-19-7

[ 5414-19-7 ]

1-Bromo-2-(2-bromoethoxy)ethane

Similarity: 0.93

Chemical Structure| 6482-24-2

[ 6482-24-2 ]

1-Bromo-2-methoxyethane

Similarity: 0.86

Chemical Structure| 54149-16-5

[ 54149-16-5 ]

2-(2-Bromoethoxy)propane

Similarity: 0.76

Chemical Structure| 111-77-3

[ 111-77-3 ]

2-(2-Methoxyethoxy)ethanol

Similarity: 0.64

Chemical Structure| 143-24-8

[ 143-24-8 ]

2,5,8,11,14-Pentaoxapentadecane

Similarity: 0.64